Introduction {#sec1}
============

Renal cell carcinoma (RCC) is one of the most common urological malignancies, accounting for 2--3% of all adult tumors, and is only secondary to bladder cancer. Its incidence is steadily increasing every year \[[@B1],[@B2]\]. Despite the recent efforts in multimodal approaches, the prognosis of patients with RCC remains poor. This situation is mainly due to delayed diagnosis, high-frequent metastasis, and recurrence after surgery \[[@B3],[@B4]\]. Therefore, it is important to further explore the mechanism of RCC and its metastasis, to obtain new insights in improving relevant therapy and exploring new therapeutic targets.

Circular RNAs (circRNAs) are formed by covalent closure of the 3′ and 5′ ends of an RNA molecule. Since circRNAs do not have 5′ or 3′ ends, they are resistant to exonuclease-mediated degradation and are presumed to be stabler than most linear RNAs in cells \[[@B5]\]. CircRNA is abundant in eukaryotic cells, highly conserved, and structurally stable, with a certain degree of organization, timing, and disease-specificity \[[@B7],[@B8]\]. Due to these features, circRNAs have become new hotspots for research. Numerous studies have shown circular RNAs to play important regulatory roles in the development of tumor \[[@B9]\]. circRNAs have been reported to contain multiple miRNA-binding sites, with which they bind to miRNAs, also defined as 'miRNA sponges', leading to the inhibition of activity of miRNAs and regulation of expression of their downstream target genes \[[@B12]\]. Liu et al. \[[@B12]\] found circRNA hsa_circ_0008039 to be highly expressed in breast cancer (BC) tissues. Circ-VANGL1 silencing inhibited cell proliferation, arrested cell-cycle progression, and reduced migration both *in vitro* and *in vivo*. E2F3 is a downstream mRNA target of miR-432-5p, and its expression is positively regulated by hsa_circ_0008039 and negatively by miR-432-5p expression in BC cells. Therefore, hsa_circ_0008039/miR-432-5p/E2F3 axis was considered as a novel essential signaling pathway involved in BC progression. Furthermore, CEP128 acts as a ceRNA to regulate SOX11 by sponging miR-145-5p, thereby reducing the inhibitory effect of miR-145-5p on SOX11 in bladder cancer \[[@B13]\].

In our study, we performed a joint analysis considering the array-based and sequence-based data of RCC. We successfully constructed the circRNA--miRNA--mRNA and circRNA--miRNA--hub gene networks. Furthermore, we also performed a series of analyses including protein--protein interaction (PPI) analysis and functional enrichment analysis.

Materials and methods {#sec2}
=====================

Data collection {#sec2-1}
---------------

We screened the expression profiles of circRNA in GEO datasets (<http://www.ncbi.nlm.nih.gov/gds/>) available till January 2019. The following strategy was used: (circular RNA or circRNA) and (renal cell cancer or renal cell carcinoma). We selected data according to the following criteria: each dataset included RCC tissue and adjacent normal tissues, and each group contained more than 3 samples. The GSE100186 dataset included 4 normal renal tissues and 4 RCC tissues. We also downloaded RCC transcriptome profiles from the TCGA database. Besides, the miRNAseq and mRNAseq data were also downloaded using the Data Transfer Tool (provided by GDC Apps) (<https://tcga-data.nci.nih.gov/>). The miRNA profiles contained 905 RCC tissues and 130 adjacent normal renal tissues, and the mRNA profiles contained 895 RCC tissues and 128 adjacent normal tissues. The R software package was used to process the downloaded files and to convert and reject the unqualified data. The data were calibrated, standardized, and log2 transformed. No ethical approval or informed consent was required in the present study since we used the publicly available data from GEO and TCGA.

Differential expression analysis {#sec2-2}
--------------------------------

The differently expressed circRNAs (DEcircRNAs) were screened using Limma package, with the criterion of \|log 2 (fold change \[FC\])\| \> 2 and adjusted *P*-value \< 0.01. Additionally, the edgeR package was used to screen differentially expressed miRNA (DEmiRNA) and mRNA (DEmRNA) with thresholds of \|log 2 (fold change \[FC\])\| \> 1 and adjusted *P*-value \< 0.05.

Construction of the ceRNA network {#sec2-3}
---------------------------------

We used the Circular RNA Interactome (CircInteractome) (<https://circinteractome.nia.nih.gov/>) database to predict the miRNA-binding sites (MREs). The target miRNAs were compared to DEmiRNA based on The Cancer Genome Atlas (TCGA); only overlapping genes were selected as candidate genes. Next, we used miRTarBase and TargetScan databases \[[@B15],[@B16]\] to predict interactions between miRNA and mRNA. Only the mRNAs recognized by both databases were considered as candidate mRNAs, and were intersected with DEmRNAs to screen the DEmRNAs targeted by DEmiRNAs. The circRNA--miRNA--mRNA regulatory network was constructed using a combination of circRNA--miRNA pairs and miRNA--mRNA pairs. Finally, the network was visualized and mapped using Cytoscape v3.7.0.

Construction of PPI network and module analysis {#sec2-4}
-----------------------------------------------

To assess the interactions between DEmRNAs, we constructed a PPI network using the Search Tool for the Retrieval of Interacting Genes (STRING) online tool, which can provide comprehensive interactions among proteins and genes. The cut-off criteria included a combined score of \> 0.9 for a PPI network and a node degree of ≥ 3 for screening hub genes. We next used the cytoHubba app to select modules of hub genes from the PPI network. The interaction network was visualized using Cytoscape software.

Gene Ontology and pathway enrichment analysis {#sec2-5}
---------------------------------------------

To assess the function of DEGs in the ceRNA network in tumorigenesis, we performed Gene Ontology (GO) annotation and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses using the clusterProfiler package of R software \[[@B17]\]. *P*-value \< 0.05 was set as the cut-off criterion.

Results {#sec3}
=======

Identification of differentially expressed genes {#sec3-1}
------------------------------------------------

A total of 6 differentially expressed circRNAs (DEcircRNAs) were screened from GSE100186 dataset, including 3 up-regulated and 3 down-regulated circRNAs ([Figure 1](#F1){ref-type="fig"}). The basic characteristics of the 6 circRNAs are listed in [Table 1](#T1){ref-type="table"}. Their basic structural patterns are shown in [Figure 2](#F2){ref-type="fig"}. The DEmiRNAs and DEmRNAs, obtained from the TCGA database, were analyzed across RCC tissues and adjacent normal tissues; we identified 187 DEmiRNAs (135 up-regulated and 52 down-regulated), and 5029 DEmRNAs (3681 up-regulated and 1348 down-regulated) ([Figure 3](#F3){ref-type="fig"}A,B).

![Heat map of the 8 differentially expressed circRNAs of the GSE100186 dataset](bsr-39-bsr20190996-g1){#F1}

![Structural patterns of the 6 circRNAs by the Cancer-Specific CircRNA (CSCD, <http://gb.whu.edu.cn/CSCD/>)\
(**A**) hsa_circ_0025135, (**B**) hsa_circ_0084927, (**C**) hsa_circ_0035442, (**D**) hsa_circ_0031594, (**E**) hsa_circ_0039238, (**F**) hsa_circ_0029340.](bsr-39-bsr20190996-g2){#F2}

![Volcano plot of differentially expressed miRNAs (**A**) and mRNAs (**B**)](bsr-39-bsr20190996-g3){#F3}

###### Basic characteristics of the 6 differently expressed circRNAs

  circRNA ID         Position                    Genomic length   Strand   Best transcript   Gene symbol   Regulation
  ------------------ --------------------------- ---------------- -------- ----------------- ------------- ------------
  hsa_circ_0031594   chr14:34398281-34400421     2140             --       NM_022073         EGLN3         Up
  hsa_circ_0029340   chr12:125292306-125294835   2529             --       NM_005505         SCARB1        Up
  hsa_circ_0039238   chr16:47162235-47165936     3701             --       NM_018092         NETO2         Up
  hsa_circ_0084927   chr8:95676924-95677424      500              \+       NM_017697         ESRP1         Down
  hsa_circ_0035442   chr15:58284902-58287337     2435             --       NM_001206897      ALDH1A2       Down
  hsa_circ_0025135   chr12:6458115-6465046       6931             --       NM_001159576      SCNN1A        Down

Construction of the ceRNA network {#sec3-2}
---------------------------------

We used the 6 DEcircRNAs, retrieved from the CircInteractome database, and identified 90 circRNA--miRNA pairs. After intersecting with the DEmiRNAs, only 19 circRNA--miRNA pairs, including 6 circRNAs and 17 DEmiRNAs, remained. Furthermore, 833 mRNAs, predicted by both databases (miRTarBase and TargetScan), were identified; these were compared with the 5028 DEmRNAs and only overlapping genes were selected as candidate genes. Results indicated 134 DEmRNAs to be involved in ceRNA network. Finally, we constructed a ceRNA network based on 6 circRNA nodes, 17 miRNA nodes, and 134 mRNA nodes in RCC ([Figure 4](#F4){ref-type="fig"}).

![The ceRNA network of circRNA--miRNA--mRNA in RCC\
The network consists of 6 circRNA nodes, 17 miRNA nodes, and 134 mRNA. Triangles indicate circRNAs, diamonds indicate miRNA, and ellipses indicate mRNA. The nodes highlighted in red and blue represent up-regulation and down-regulation, respectively.](bsr-39-bsr20190996-g4){#F4}

Protein--protein network analysis {#sec3-3}
---------------------------------

Based on the DEmRNAs, PPI network was constructed, involving 37 nodes and 50 edges ([Figure 5](#F5){ref-type="fig"}A). In order to identify hub genes in the process of RCC carcinogenesis, closeness centrality of DEmRNAs was calculated using cytoHubba plugin, and the top 8 hub genes were found to be BUB1, RAD51, GINS2, CDC6, MELK, OIP5, PLK1, and TRIP13 ([Figure 5](#F5){ref-type="fig"}B). We next constructed a circRNA--miRNA--hub gene sub-network ([Figure 6](#F6){ref-type="fig"}), including 8 ceRNA regulatory modules.

![Identification of hub genes from the PPI network\
(**A**) PPI network of 134 genes, consisting of 37 nodes and 50 edges. (**B**) PPI network of 8 hub genes extracted from (A). The node color changes gradually from yellow to red in ascending order according to the log~2~(foldchange) of genes.](bsr-39-bsr20190996-g5){#F5}

![CircRNA--miRNA--hub gene network\
The network consists of 3 circRNAs, 4 miRNAs, and 8 hub genes. Vs indicate circRNAs, diamonds indicate miRNA, and round rectangles indicate mRNA.](bsr-39-bsr20190996-g6){#F6}

Functional assessment of DEmRNAs {#sec3-4}
--------------------------------

Our data revealed that the mRNAs associated with biological process (BP) included those in regulation of mitotic metaphase/anaphase transition, regulation of metaphase/anaphase transition of cell cycle, metaphase/anaphase transition of mitotic cell cycle, metaphase/anaphase transition of cell cycle, and regulation of mitotic sister chromatid separation. Meanwhile, the mRNAs related to cellular components (CC) were most relevant to chromosomal region (*P* \<0.05). In terms of molecular function (MF), mRNAs were mostly enriched in catalytic activity, and acting on DNA (*P* \<0.05). The top five GO terms are indicated in [Table 2](#T2){ref-type="table"}, according to the *P*-value. KEGG analysis showed cell cycle pathway to be associated with the mRNAs (*P* \<0.05).

###### The top 5 GO terms enriched by DEmRNA involved in the ceRNA network

  Categories   Terms        Description                                                 *P*-value   *P*-adjusted   Genes              Counts
  ------------ ------------ ----------------------------------------------------------- ----------- -------------- ------------------ --------
  BP           GO:0030071   Regulation of mitotic metaphase/anaphase transition         1.05E-06    7.64E-05       BUB1/CDC6/TRIP13   3
               GO:1902099   Regulation of metaphase/anaphase transition of cell cycle   1.11E-06    7.64E-05       BUB1/CDC6/TRIP13   3
               GO:0007091   Metaphase/anaphase transition of mitotic cell cycle         1.26E-06    7.64E-05       BUB1/CDC6/TRIP13   3
               GO:0044784   Metaphase/anaphase transition of cell cycle                 1.34E-06    7.64E-05       BUB1/CDC6/TRIP13   3
               GO:0010965   Regulation of mitotic sister chromatid separation           1.50E-06    7.64E-05       BUB1/CDC6/TRIP13   3
  CC           GO:0098687   Chromosomal region                                          0.000331    0.007594       BUB1/RAD51/OIP5    3
               GO:0005657   Replication fork                                            0.00037     0.007594       RAD51/GINS2        2
               GO:0000794   Condensed nuclear chromosome                                0.000716    0.009784       BUB1/RAD51         2
               GO:0000775   Chromosome, centromeric region                              0.002878    0.024971       BUB1/OIP5          2
               GO:0000793   Condensed chromosome                                        0.003585    0.024971       BUB1/RAD51         2
  MF           GO:0140097   Catalytic activity, acting on DNA                           0.003358    0.032713       RAD51/GINS2        2
               GO:0043138   3′-5′ DNA helicase activity                                 0.005912    0.032713       GINS2              1
               GO:0043142   Single-stranded DNA-dependent ATPase activity               0.005912    0.032713       RAD51              1
               GO:0000400   Four-way junction DNA binding                               0.007272    0.032713       RAD51              1
               GO:0034185   Apolipoprotein binding                                      0.007272    0.032713       LPL                1

Discussion {#sec4}
==========

Abnormal expression of non-coding RNAs plays an important role in the development and progression of multiple tumors \[[@B18],[@B19]\]. With the advent of high-throughput sequencing technologies in recent years, along with the continuous maturity and development of bioinformatics, circRNAs have been increasingly identified in multiple species. The discovery of circRNA expands our knowledge of the types and functions of non-coding RNA family. Several studies have unveiled the mechanism of participation of circRNAs in the regulation of malignant biological processes \[[@B20],[@B21]\]. CircRNAs have been shown to be associated with the development of different tumors, thus implying their potential to serve as biomarkers of malignancies \[[@B22]\]. However, the exact role of circRNAs in RCC still remains largely unclear. In the present study, we first integrated circRNA, miRNA, and mRNA data of RCC tissues and non-tumor tissues from Gene Expression Omnibus (GEO) datasets and TCGA database, and constructed the circRNA--miRNA--mRNA regulatory network.

Several studies have shown the expression level of circRNA to be dysregulated in RCC, and to be associated with pathogenesis and prognosis, thus suggesting them as potential tumor-associated biomarkers \[[@B25]\]. Wang et al. \[[@B25]\] analyzed 52 pairs of RCC samples and normal renal samples and found hsa_circ_0001451 to be significantly down-regulated in RCC tissues, besides being linked to clinicopathological features and OS. *In vitro* silencing of Hsa_circ_0001451 promoted tumor growth; therefore, hsa_circ_0001451 may be a potential prognostic biomarker for RCC. Similarly, elevated circPCNXL2 was observed in RCC tissues and was associated with poor OS of patients with RCC. Knockdown of circPCNXL2 inhibited proliferation and *in vitro* invasion, and reduced tumor growth *in vivo*. Furthermore, circPCNXL2 was found to bind to miR-153 as an miRNA sponge to regulate the expression of ZEB2 in RCC progression \[[@B26]\]. In our study, a total of 6 circRNAs (hsa_circ_0084927, hsa_circ_0029340, hsa_circ_0035442, hsa_circ_0025135, hsa_circ_0039238, and hsa_circ_0031594) were identified to be involved in the ceRNA network. Among them, hsa_circ_0084927 was found to be up-regulated in lung adenocarcinoma-associated malignant pleural effusion and was used to construct the ceRNA network \[[@B28]\]. However, none of the other 5 circRNAs has yet been reported.

MiRNAs regulate approximately 60% of human genes, including proto-oncogenes and tumor suppressors, suggesting the correlation between miRNAs and tumors. MiRNAs form a large class of endogenous non-coding RNAs that are 19--25 nucleotides in length, regulating cell proliferation, differentiation, apoptosis, and migration \[[@B29]\]. They can bind to the 3′ untranslated region (UTR) of the target gene by means of partial pairing of base pairs to inhibit the expression of target gene at post-transcriptional level \[[@B30]\]. In the present study, we identified 17 DEmiRNAs in the ceRNA network. Among them, several miRNAs have been reported to play important roles in the initiation and development of RCC, such as miR-182, miR-136, and miR-629 \[[@B31]\]. To further identify the key circRNAs participating in the regulatory network, we established the PPI network, thereby screening 8 hub genes. GO and KEGG pathway analysis suggested these DEmRNAs to be involved in many important tumor-associated biological functions and pathways. Furthermore, we established circRNA--miRNA--hub gene network, including 8 circRNA--miRNA--mRNA axes. However, since the results are based on bioinformatics, further in-depth studies would be recommended to verify the possible role of the 8 axes in RCC.

Conclusions {#sec5}
===========

We obtained the expression profiles of RNAs and constructed ceRNA networks by analyzing the data from GEO and TCGA. Our study provides novel insights into the circRNA-related ceRNA network in RCC and suggests potential therapeutic targets.
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